Boea Wisdom
柏意慧心
Boea Wisdom (柏意慧心) is a Hangzhou-based medtech company in Linear Capital's portfolio, focused on vascular interventional surgery planning software . Its flagship product DetecMicro® became China's first NMPA Class III-approved software in this category in November 2023 . The company has since expanded into AI-powered surgical simulation through the Symphony Platform, developed in partnership with Siemens Medical , and signed a strategic cooperation agreement with Medtronic in late 2024 to build a full-process diagnostic and treatment chain covering imaging acquisition, digital twin, and smart device development . As of early 2026, Boea Wisdom had raised a new round of funding at the tens-of-millions level to advance product R&D, multi-center clinical trials, and commercialization .
AI-generated — may contain errors, please verify.
Coverage
After the Start of Summer, Growing Without Reserve | Linear Quarterly
Abundant sunshine, lush growth.
线性资本·Before the Start of Winter, Building Inner Strength | Linear Quarterly
Fearless through the winter, growing inward.
线性资本·The First Newsletter of Autumn | Linear Quarterly
Cycles turn, and Wanwu Capital begins to harvest.
线性资本·Linear Capital Portfolio Company | Boyi Huixin Secures China's First NMPA Class III Approval for Vascular Interventional Surgery Planning Software!
On November 1, 2023, DetecMicro®, a vascular interventional surgical planning software independently developed by Boyi Huixin (Hangzhou) Network Technology Co., Ltd. ("Boyi Huixin"), a portfolio company of Linear Capital, officially received Class III medical device registration approval (National Medical Device Registration Certificate No. 20233211596) from the National Medical Products Administration (NMPA). DetecMicro
线性资本·Linear Capital portfolio company **Baiyi Huixin** launches **DetecMicro**, a vascular interventional surgery planning software
On June 16, 2023, **Baiyi Huixin held its product launch event in Beijing under the theme "Seeing the Small to Know the Great, Moving to See the Future." At the event, the company unveiled its DetecMicro vascular interventional surgical planning software.**
线性资本·
